Identification and quantification of proteins differentially secreted by a pair of normal and malignant breast-cancer cell lines

Proteomics

Volumn 9, Issue 1, 2009, Pages 182-193

  Liang, Xiquan ^a   Huuskonen, Jarkko ^a   Hajivandi, Mahbod ^a   Manzanedo, Raul ^a   Predki, Paul ^a   Amshey, Joseph R ^a   Pope, R Marshall ^a  

^a INVITROGEN CORPORATION   (United States)

Author keywords

Breast cancer; Protein expression; Protein marker discovery; Stable isotope labelling; Tandem mass spectrometry

Indexed keywords

CHEMOKINE; COLLAGEN; COLLAGEN TYPE 18; ENDOSTATIN; GROWTH FACTOR; INHIBIN; MACROPHAGE MIGRATION INHIBITION FACTOR; PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR; TRANSCRIPTION FACTOR RUNX2; TUMOR NECROSIS FACTOR; AMINO ACID; BIOLOGICAL MARKER; CYTOKINE; PROTEIN; SIGNAL PEPTIDE;

ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; ISOTOPE LABELING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; STROMA; TECHNOLOGY; UPREGULATION; WESTERN BLOTTING; BREAST TUMOR; CELL LINE; CHEMISTRY; COMPARATIVE STUDY; CULTURE TECHNIQUE; EVALUATION; FEMALE; GENE EXPRESSION REGULATION; METABOLISM; REPRODUCIBILITY; SECRETION; TUMOR CELL LINE;

AMINO ACIDS; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CELL CULTURE TECHNIQUES; CELL LINE; CELL LINE, TUMOR; CYTOKINES; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTEINS; REPRODUCIBILITY OF RESULTS; SERINE PROTEINASE INHIBITORS;

EID: 59449107627     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700957     Document Type: Article

References (30)

1. Zagury, D., Burny, A., Gallo, R. C. Toward a new generation of vaccines: the anti-cytokine therapeutic vaccines. Proc. Natl. Acad. Sci. USA 2001, 98, 8024-8029.
2. Walter, P., Gilmore, R., Blobel, G. Protein translocation across the endoplasmic reticulum. Cell 1984, 38, 5-8.
3. Prieto, D., Conrads, T. P., Scudiero, D. A., Veenstra,T. D., Issaq, H. J. Profiling of secreted proteins from human ovarian cancer cell lines by surface-enhanced laser desorption ionization time-of-flight mass spectrometry. J. Liquid Chromatogr. Related Technol. 2003, 26, 2315-2328.
4. Gronborg, M., Kristiansen, T. Z., Iwahori, A., Chang, R. et al., Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol. Cell. Proteomics 2006, 5, 157-171.
5. An, E., Lu, X., Flippin, J., Devaney, J. M. et al., Secreted proteome profiling in human RPE cell cultures derived from donors with age related macular degeneration and age matched healthy donors. J. Proteome Res. 2006, 5, 2599-2610.
6. Buchholz, M., Biebl, A., Neesse, A., Wagner, M. et al., SERPINE2 (protease nexin I) promotes extracellular matrix production and local invasion of pancreatic tumors in vivo. Cancer Res. 2003, 63, 4945-4951.
7. Liang, X., Zhao, J., Hajivandi, M., Wu, R. et al., Quantification of membrane and membrane-bound proteins in normal and malignant breast cancer cells isolated from the same patient with primary breast carcinoma. J. Proteome Res. 2006, 5, 2632-2641.
8. Chen, Y., Zhang, Y., Yin, Y., Gao, G. et al., SPD-a web-based secreted protein database. Nucleic Acids Res. 2005, 33, D169-173.
9. Omenn, G. S., States, D. J., Adamski, M., Blackwell, T. W. et al., Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 2005, 5, 3226-3245.
10. Lochter, A., Bissell, M. J. Involvement of extracellular matrix constituents in breast cancer. Seminars in Cancer Biol. 1995, 6, 165-173.
11. Siriwardena, B. S. M. S., Kudo, Y., Ogawa, I., Kitagawa, M. et al., Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer. Br. J. Cancer2006, 95, 1396-1403.
12. Gillan, L., Matei, D., Fishman, D. A., Gerbin, C. S. et al., Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res. 2002, 62, 5358-5364.
13. Sasaki, H., Yu, C. Y., Dai, M., Tam, C. et al., Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer. Breast Cancer Res. Treat. 2003, 77, 245-252.
14. Andreasen, P. A., Egelund, R., Petersen, H. H. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell. Mol. Life Sci. 2000, 57, 25-40.
15. Maurizio, M., Sweeney, S. M., San Antonio, J. D., Fu, J., Ozzo, R. V. Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J. Biol. Chem. 2003, 278, 4238-4249.
16. Candia, B. J., Hines, W. C., Heaphy, C. M., Griffith, J. K., Orlando, R. A. Protease nexin-1 expression is altered in human breast cancer. Cancer Cell Int. 2006, 6, 16-22.
17. Schneiderman, J., Sawdey, M. S., Keeton, M. R., Bordin, G. M. et al., Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc. Natl. Acad. Sci. USA 1992, 89, 6998-7002.
18. Kanoh, Y., Ohtani, N., Mashiko, T., Ohtani, S. etal., Levels of alpha 2 macroglobulin can predict bone metastases in prostate cancer. Anticancer Res. 2001, 21, 551-556.
19. Buchholz, M., Biebl, A., Neesse, A., Wagner, M. etal., SER-PINE2 (protease nexin I) promotes extracellular matrix production and local invasion of pancreatic tumors in vivo. Cancer Res. 2003, 63, 4945-4951.
20. Ito, C., Sato, H., Ando, K., Watanabe, S. et al., Serum stem cell growth factor for monitoring hematopoietic recovery following stem cell transplantation. Bone Marrow Transplantation 2003, 32, 391-398.
21. Yasuda, A., Sawai, H., Takahashi, H., Ochi, N. et al., The stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells. Mol. Cancer 2006, 5, 46-55.
22. Barreda, D. R., Hanington, P. C., Belosevic, M., Regulation of myeloid development and function by colony stimulating factors. Dev. Comp. Immunol. 2004, 28, 509-554.
23. Andreani, C. L., Payne, D. W., Packman, J. N., Resnick, C. E. et al., Cytokine-mediated regulation of ovarian function. Tumor necrosis factor alpha inhibits gonadotropin-supported ovarian androgen biosynthesis. J. Biol. Chem. 1991, 266, 6761-6766.
24. Roth, W., Wagenknecht, B., Klumpp, A., Naumann, U. et al., APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis. Cell Death Differ. 2001, 8, 403-410.
25. Cao, W. G., Morin, M., Sengers, V., Metz, C. et al., Tumor necrosis factor-alpha up-regulates macrophage migration inhibitory factor expression in endometrial stromal cells via the nuclear transcription factor NF-kappaB. Hum. Reprod. 2006, 21, 421-428.
26. Bando, H., Matsumoto, G., Bando, M., Muta, M. et al., Expression of macrophage migration inhibitory factor in human breast cancer: association with nodal spread. Jpn. J. Cancer Res. 2002, 93, 389-396.
27. Jellinek, D. A., Chang, A. C., Larsen, M. R., Wang, X. et al., Stanniocalcin 1 and 2 are secreted as phosphoproteins from human fibrosarcoma cells. Biochem. J. 2000, 350, 453-461.
28. Varghese, R., Gagliardi, A. D., Bialek, P. E., Yee, S. et al., Overexpression of human stanniocalcin affects growth and reproduction in transgenic mice. Endocrinology 2002, 143, 868-876.
29. Scaltriti, M., Baselga, J. The epidermal growth factor receptor pathway: a model for targeted therapy. Clin. Cancer Res. 2006, 12, 5268-5272.
30. Asem, E. K., Novero, R. P. Stimulation of fibronectin production and deposition by chicken granulosa cells in vitro by epidermal growth factor and transforming growth factor alpha. Reproduction 1994, 101, 375-384.